Predictors of Long-Term Survival After Resection of Esophageal Carcinoma With Nonregional Nodal Metastases

Annals of Thoracic Surgery

Volumn 88, Issue 1, 2009, Pages 186-193

  Lee, Paul C ^a   Port, Jeffrey L ^a   Paul, Subroto ^a   Stiles, Brendon M ^a   Altorki, Nasser K ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RISK ASSESSMENT;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CAUSE OF DEATH; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 67649807404     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.03.079     Document Type: Article

References (24)

1. American Joint Committee on Cancer. AJCC cancer staging manual. 6th ed. (2002), Lippincott-Raven, Philadelphia 91-103
2. Rice T.W., Blackstone E.H., Rybicki L.A., et al. Refining esophageal cancer staging. J Thorac Cardiovasc Surg 125 (2003) 1103-1113
3. Christie N.A., Rice T.W., De Camp M.M., et al. M1a/M1b esophageal carcinoma: clinical relevance. J Thorac Cardiovasc Surg 118 (1999) 900-907
4. Steup W.H., De Leyn P., Deneffe G., et al. Tumors of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thorac Cardiovasc Surg 111 (1996) 85-95
5. Trovo M., Bradley J., El Naqa I., et al. Esophageal carcinoma with celiac nodal metastases; curative or palliative?. J Thorac Oncol 3 (2008) 751-755
6. Tachimori Y., Kato H., and Watanabe H. Surgery for thoracic esophageal carcinoma with clinically positive cervical nodes. J Thorac Cardiovasc Surg 116 (1998) 954-959
7. Lerut T., Nafteux P., Moons J., et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 240 (2004) 962-974
8. Altorki N.K., and Skinner D. Should en-bloc esophagectomy be the standard of care for esophageal carcinoma?. Ann Surg 234 (2001) 581-587
9. Orringer M.B., Marshall B., and Iannettoni M.D. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg 230 (1999) 392-403
10. Rizk N., Venkatraman E., Park B., et al. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg 132 (2006) 1374-1381
11. Korst R.J., Rusch V.W., Venkatraman E., et al. Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 115 (1998) 660-670
12. Altorki N., Kent M., Ferrara C., and Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 236 (2002) 177-183
13. Akiyama H., Tsurumaru M., Udagawa Y., et al. Systemic lymph node dissection for cancer: effective or not?. Dis Esophagus 7 (1994) 1-12
14. Dhar D.K., Tachibana M., Kinukawa N., et al. The prognostic significance of lymph node size in patients with squamous esophageal cancer. Ann Surg Oncol 9 (2002) 1010-1016
15. Rouvière H. Lymphatics of the larynx, the trachea, and the oesophagus. Anatomy of the human lymphatic system (1938), Edwards Brothers, Ann Arbor 57-62
16. Hofstetter W., Correa A.M., Bekele N., et al. Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg 84 (2007) 365-375
17. Alexiou C., Khan L.A., Black E., et al. Survival after esophageal resection for carcinoma: The importance of the histologic cell type. Ann Thorac Surg 82 (2006) 1073-1077
18. Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355 (2006) 11-20
19. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet 359 (2002) 1727-1733
20. Boige V., Pignon J., Saint-Aubert B., et al. Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial. J Clin Oncol 25 suppl 1 (2007) Abstract 4510
21. Thirion P.G., Michiels S., Le Maitre A., et al. Individual patient data-based meta-analysis assessing pre-operative chemotherapy in resectable oesophageal adenocarcinoma. J Clin Oncol 25 suppl 1 (2007) Abstract 4512
22. Shinoda M., Hatooka S., Mori S., and Mitsudomi T. Clinical aspects of multimodality therapy for resectable locoregional esophageal cancer. Ann Thorac Cardiovasc Surg 12 (2006) 234-241
23. Ando N., Iizuka T., Ide H., et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204. J Clin Oncol 21 (2003) 4592-4596
24. Ando N., Iizuka T., Kakegawa T., et al. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg 114 (1997) 205-209